More than 2.5 million bottles of eye drops have been recalled in the United States.

The U.S. Food and Drug Administration (FDA) announced that prednisolone acetate ophthalmic suspension eye drops produced by Lupin Pharmaceuticals Inc. have been voluntarily recalled due to the risk of foreign object contamination.

A total of 2,530,182 bottles of the product are being recalled. The medication, which is prescribed for treating redness, itching, and inflammation linked to eye infections and various eye conditions, is used under medical supervision.

Which products have been recalled?

The recall covers 5 mL, 10 mL, and 15 mL packaging sizes of prednisolone acetate ophthalmic suspension, 1%.

Authorities have confirmed that the affected products were manufactured at Lupin Limited’s facility in India, with the recall encompassing numerous batch numbers.

The U.S. Food and Drug Administration has classified it as a **Class II** medical device.

Last month’s recall was classified by the FDA as a **Class II** incident last week.

The FDA states that Class II recalls are initiated when a product’s use may cause temporary health issues or require medical intervention to resolve.

Authorities have urged consumers who have used recalled products to check the batch numbers on the items they possess and to contact health professionals if necessary.

For the full content and details,Original source.You can review it.